{"id":3056,"date":"2017-09-25T17:07:03","date_gmt":"2017-09-25T21:07:03","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3056"},"modified":"2017-09-25T17:11:34","modified_gmt":"2017-09-25T21:11:34","slug":"secondaries-announced-9-25-17","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-9-25-17\/","title":{"rendered":"Secondaries Announced 9.25.17"},"content":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n

If having\u00a0real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,\u00a0inquire about a subscription today!<\/a><\/p>\n

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n

Company: Catalent Inc.<\/strong>
\nSymbol: CTLT
\nPrice: Last Trade $40.79
\nTrade Date: 9\/27
\nShares: 6.1 million ($250m cash raise)
\nUnderwriter(s) : Morgan Stanley, J.P. Morgan, RBC Capital, BofA Merrill Lynch
\nDescription: They are the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products
\nRating: Subscription Needed<\/a><\/p>\n

Company: Kadmon Holdings Inc.<\/strong>
\nSymbol: KDMN
\nPrice: Last Trade $3.79
\nTrade Date: 9\/26
\nRe-Offer Range: Subscription Needed<\/a>
\nShares: 18.5 million ($70 million cash raise)
\nUnderwriter(s) : Jefferies, Piper Jaffray
\nDescription: Kadmon Holdings, Inc. is a fully integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs.
\nRating = Subscription Needed<\/a><\/p>\n

Company: Sabra Health Care REIT<\/strong>
\nSymbol: SBRA
\nPrice: Last Trade $22.33
\nTrade Date: 9\/26
\nShares: 16 million
\nRe-Offer Range: Subscription Needed<\/a>
\nUnderwriter(s) : Barclays, Citigroup, BMO Capital Markets, SunTrust Robinson Humphrey, Credit Agricole CIB, MUFG, Raymond James, UBS Investment Bank, Morgan Stanley, Stifel
\nDescription: They are a Maryland corporation, is a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry.
\nRating = Subscription Needed<\/a><\/p>\n

Company: CoStar Group, Inc.<\/strong>
\nSymbol: CSGP
\nPrice: Last Trade $279.20
\nTrade Date: 9\/28
\nShares: 2.7 million ($750 million cash raise)
\nUnderwriter(s) : J.P. Morgan, Goldman Sachs & Co., Citigroup, BofA Merrill Lynch, SunTrust, Wells Fargo Securities
\nDescription: CoStar Group, Inc. is an American commercial real estate information and marketing provider with headquarters in Washington, DC.
\nRating = Subscription Needed<\/a><\/p>\n

Company: Cloudera, Inc<\/strong>
\nSymbol: CLDR
\nPrice: Last Trade $18.38
\nTrade Date: 9\/28
\nShares: 12 million
\nUnderwriter(s) : Morgan Stanley, J.P. Morgan, Allen & Co., BofA Merrill Lynch, Citigroup, Deutsche Bank
\nDescription: Cloudera, Inc. operates a data management, machine learning, and analytics software platform in the United States, Europe, and Asia.
\nCo-Manager(s): Stifel, JMP Securities, Raymond James
\nRating = Subscription Needed<\/a><\/p>\n

Company: TherapeuticsMD, Inc.-BLOCK<\/strong>
\nSymbol: TXMD
\nPrice: Last Trade $6.07
\nTrade Date: 9\/26
\nShares: 12.4 million
\nRe-Offer Range: Subscription Needed<\/a>
\nUnderwriter(s) : J.P. Morgan
\nDescription: TherapeuticsMD, Inc. is a women’s healthcare company engaged in creating and commercializing products for women
\nRating = Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[1161,1359,166,1035,519,127],"class_list":["post-3056","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-cldr","tag-csgp","tag-ctlt","tag-kdmn","tag-sbra","tag-txmd"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3056"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3056\/revisions"}],"predecessor-version":[{"id":3057,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3056\/revisions\/3057"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}